Literature DB >> 11779128

Trypanosoma cruzi uses a 45-kDa mucin for adhesion to mammalian cells.

Corey W Turner1, Maria F Lima, Fernando Villalta.   

Abstract

A set of monoclonal antibodies that recognizes a Trypanosoma cruzi 45-kDa protein was produced and used to characterize this molecule and study its role in trypanosome adhesion to heart myoblasts. We found that the 45-kDa protein is a surface mucin, is expressed only in invasive trypomastigotes, but not in noninvasive epimastigotes or amastigotes, and is released by the trypanosome in culture medium. One of the monoclonal antibodies (Mab B5) from this set inhibits the attachment of trypomastigotes to heart myoblasts preventing trypanosome entry, whereas the others (Mabs B4 and F1) do not. This inhibition was seen with the B5 hybridoma culture supernatant, with the purified Mab B5 IgG or with Mab B5 Fab fragments. These novel findings identify the 45-kDa mucin as a new T. cruzi ligand that is used by invasive forms of this organism to adhere to heart myoblasts. (c)2002 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779128     DOI: 10.1006/bbrc.2001.6189

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Crystal structures of Trypanosoma cruzi UDP-galactopyranose mutase implicate flexibility of the histidine loop in enzyme activation.

Authors:  Richa Dhatwalia; Harkewal Singh; Michelle Oppenheimer; Pablo Sobrado; John J Tanner
Journal:  Biochemistry       Date:  2012-06-05       Impact factor: 3.162

2.  REGULATION of the EXTRACELLULAR MATRIX INTERACTOME by Trypanosoma cruzi.

Authors:  Tatiana C Cardenas; Candice A Johnson; Siddharth Pratap; Pius N Nde; Vyacheslav Furtak; Yuliya Y Kleshchenko; Maria F Lima; Fernando Villalta
Journal:  Open Parasitol J       Date:  2010

3.  Molecular cloning of a Trypanosoma cruzi cell surface casein kinase II substrate, Tc-1, involved in cellular infection.

Authors:  Swinburne A J Augustine; Yuliya Y Kleshchenko; Pius N Nde; Siddharth Pratap; Edward A Ager; James M Burns; Maria F Lima; Fernando Villalta
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Structures containing galectin-3 are recruited to the parasitophorous vacuole containing Trypanosoma cruzi in mouse peritoneal macrophages.

Authors:  Lissa Catherine Reignault; Emile Santos Barrias; Lia Carolina Soares Medeiros; Wanderley de Souza; Tecia Maria Ulisses de Carvalho
Journal:  Parasitol Res       Date:  2014-04-24       Impact factor: 2.289

Review 5.  Molecular mechanisms of host cell invasion by Trypanosoma cruzi.

Authors:  Conrad L Epting; Bria M Coates; David M Engman
Journal:  Exp Parasitol       Date:  2010-06-18       Impact factor: 2.011

6.  Molecular Dynamics Simulations of Substrate Release from Trypanosoma cruzi UDP-Galactopyranose Mutase.

Authors:  Rodrigo Cossio-Pérez; Gustavo Pierdominici-Sottile; Pablo Sobrado; Juliana Palma
Journal:  J Chem Inf Model       Date:  2019-01-17       Impact factor: 4.956

Review 7.  Perspectives on the Trypanosoma cruzi-host cell receptor interactions.

Authors:  Fernando Villalta; Julio Scharfstein; Anthony W Ashton; Kevin M Tyler; Fangxia Guan; Shankar Mukherjee; Maria F Lima; Sandra Alvarez; Louis M Weiss; Huan Huang; Fabiana S Machado; Herbert B Tanowitz
Journal:  Parasitol Res       Date:  2009-03-13       Impact factor: 2.289

Review 8.  Molecular analysis of early host cell infection by Trypanosoma cruzi.

Authors:  Fernando Villalta; M Nia Madison; Yuliya Y Kleshchenko; Pius N Nde; Maria F Lima
Journal:  Front Biosci       Date:  2008-05-01

9.  Regulation and use of the extracellular matrix by Trypanosoma cruzi during early infection.

Authors:  Pius N Nde; Maria F Lima; Candice A Johnson; Siddharth Pratap; Fernando Villalta
Journal:  Front Immunol       Date:  2012-11-06       Impact factor: 7.561

Review 10.  Targeting UDP-galactopyranose mutases from eukaryotic human pathogens.

Authors:  Karina Kizjakina; John J Tanner; Pablo Sobrado
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.